Dendritic Cell-based Immunotherapy in Mesothelioma

Conditions:	Malignant Pleural Mesothelioma
Start Date:	January 1, 2006
Phase:	Phase I
Status:	Completed
NCT ID:	NCT00280982
Study Type:	Interventional
Intervention:	Biological: tumor lysate-loaded autologous dendritic cells
Study Design:	Allocation: Non-Randomized\|Control: Uncontrolled\|Endpoint Classification: Efficacy Study\|Intervention Model: Single Group Assignment\|Masking: Open Label\|Primary Purpose: Treatment
Results:	No Results Available
Sponsors:	Erasmus Medical Center
Ages:	Adult\|Senior
Enrollment:	10
Funded By:	Other
First Received:	January 20, 2006
End Date:	September 1, 2009
Last Updated:	November 15, 2010
Last Verified:	November 1, 2010

First Name

Last Name

Phone Number

Email

Zip Code

Details: Please Include Diagnosis Date

Type The Number Below: